Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project

Table 4

Psychosocial variables, HRQOL (unadjusted means and standard errors).

	Transition group (ages 16–25)	Younger adults (ages 26–36)	Older adults (ages 37–64)	value for overall ANOVA
Somatic symptom score	5.4 (0.5)	7.3 (0.4)	7.9 (0.4)	<0.002
Coping (CSQ-SCD)
Active	2.6 (0.1)	2.9 (0.1)	3.0 (0.1)	0.078
Affective/emotional focused	2.1 (0.2)	2.6 (0.1)	2.5 (0.1)	0.058
Passive/behavioral adherence	3.6 (0.1)	4.2 (0.1)	4.0 (0.1)	0.008
HRQOL
PCS	40.8 (1.3)	34.0 (1.1)	33.0 (0.9)	<0.001
MCS	49.7 (1.5)	45.5 (1.5)	47.1 (1.1)	0.102
Social support	5.5 (0.2)	5.5 (0.2)	5.9 (0.1)	0.112
Stress	18.3 (1.34)	21.1 (1.2)	19.4 (1.0)	0.263

Higher scores are better, except for the stress measure.
Multiple comparisons (Tukey): significant differences in unadjusted analyses, transition versus younger adults ; transition versus older adults ; younger versus older adults .
Coping is measured using the Coping Strategies Questionnaire-SCD (CSQ-SCD).
HRQOL = Health Related Quality of Life, Measured using MOS SF-36: PCS = physical summary score. MCS = mental summary score.